Tubulin-tyrosine ligase-like protein 12 (TTLL12) - elevated expression in oral squamous cell carcinoma and its clinical prognostic implications

Q: What was the main purpose of the study on TTLL12 in OSCC?

To investigate TTLL12 expression in oral squamous cell carcinoma and explore its associations with clinicopathological characteristics and patient prognosis.

Q: How were TTLL12 expression levels measured?

TTLL12 expression was detected by immunohistochemistry (IHC) on paraffin sections from 162 OSCC tissues and 30 adjacent normal tissues.

Q: What clinical factors were associated with high TTLL12 expression?

High TTLL12 expression correlated with increased tumor size, advanced clinical stage, cervical lymph node metastasis, and higher risk of new distant metastasis during follow-up.

Q: Does TTLL12 have prognostic value for OSCC survival?

Yes. Multivariate Cox regression showed TTLL12 as an independent prognostic factor, and patients with high TTLL12 had shorter overall survival times than those with low TTLL12.

Sep 23, 2026

Uploaded by PakDamar76

Background aims to clarify TTLL12 expression patterns in oral squamous cell carcinoma (OSCC) and determine associations with clinicopathological features and patient prognosis. Methods analyze 162 OSCC tumor specimens and 30 adjacent normal tissues collected from surgical cases between May 2014 and December 2018, using immunohistochemistry and SPSS 24.0. Results show higher TTLL12 in OSCC, correlated with larger tumors, advanced stage, cervical node metastasis, and worse follow-up outcomes. Conclusions link elevated TTLL12 to enhanced tumor growth and metastasis, indicating poor prognosis and biomarker potential.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages9

Reading Time23 min

AccessFree to download

Background

Role of TTLL12 in OSCC

Methods

Tissue collection and IHC detection

Results

Correlation with clinicopathological features

Prognostic value by Cox regression

Conclusions

Wang et al. BMCOral Health (2026) 26:1447 BMC Oral Health [https://doi.org/10.1186/s12903-026-08569-z](https://doi.org/10.1186/s12903-026-08569-z) RESEARCH Open Access Tubulin-tyrosine ligase-like protein 12(TTLL12): elevated expression in oralsquamous cell carcinoma and its clinical prognostic implications Yu-lu Wang1, Yi-run Wang 1, Lin-sheng Dong2 andYa-dong Li 1* Abstract Background The aim of the present study was to investigate the expression of tubulin-tyrosine ligase-like protein 12 (TTLL12) in oral squamous cell carcinoma (OSCC) and to explore its potential associations with clinicopathological characteristics and patient prognosis. Methods A total of 162 OSCC tissue samples and 30 adjacent normal tissue samples were collected from patients who underwent surgical resection at the First Affiliated Hospital of Chongqing Medical University between May 2014 and December 2018. Paraffin sections were prepared, and TTLL12 expression was detected via immunohistochemistry (IHC) . The data were analyzed using SPSS 24.0 software. Results Immunohistochemical analysis revealed that TTLL12 expression was significantly higher in OSCC tissues than in normal controls. High TTLL12 expression was significantly correlated with increased tumor size, advanced clinical stage, cervical lymph node metastasis, and risk of new distant metastasis during the follow-up period (P < 0. 05) . Multivariate Cox regression analysis revealed that TTLL12 expression was an independent prognostic factor for OSCC patient survival (P = 0 . 035) . Moreover, patients with high TTLL12 expression had significantly shorter overall survival (OS) times than those with low TTLL12 expression (P < 0. 001) . Conclusions Elevated TTLL12 expression is associated with enhanced tumor growth and metastasis in OSCC, leading to poor prognosis. These findings suggest that TTLL12 is a potential biomarker for prognostic assessment in patients with OSCC. Keywords Oral squamous cell carcinoma, TTLL12, Immunohistochemistry, Prognosis *Correspondence: Ya-dong Li [llxxyydd2006@sina.com](llxxyydd2006@sina.com) 1Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P. R. China 2Renji Hospital, School of Medical Chongqing University, Chongqing, China © The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.) Wang et al. BMC Oral Health (2026) 26:1447 Background Malignant tumors represent a major global health challenge. According to the latest data from the International Agency for Research on Cancer, there were approximately 20 million new cancer cases and nearly 10 million cancer-related deaths worldwide in 2022 [1]. Among various cancers, oral cancer has garnered significant attention because of its high incidence and mortality rates [2], particularly in Asia, where it has high prevalence [3]. Oral squamous c

FAQs

What was the main purpose of the study on TTLL12 in OSCC?

To investigate TTLL12 expression in oral squamous cell carcinoma and explore its associations with clinicopathological characteristics and patient prognosis.

How were TTLL12 expression levels measured?

TTLL12 expression was detected by immunohistochemistry (IHC) on paraffin sections from 162 OSCC tissues and 30 adjacent normal tissues.

What clinical factors were associated with high TTLL12 expression?

High TTLL12 expression correlated with increased tumor size, advanced clinical stage, cervical lymph node metastasis, and higher risk of new distant metastasis during follow-up.

Does TTLL12 have prognostic value for OSCC survival?

Yes. Multivariate Cox regression showed TTLL12 as an independent prognostic factor, and patients with high TTLL12 had shorter overall survival times than those with low TTLL12.

Sep 23, 2026

Uploaded by PakDamar76